促销时间表 Odonate, Inc.
先进的时间表
简单图表
关于公司 Odonate, Inc.
Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.| IPO date | 2017-12-07 |
|---|---|
| ISIN | US6760791060 |
| Industry | Capital Markets |
| Sector | Financials |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.odonate.com |
| Цена ао | 50000 |
| 每月价格变化: | +25% (40000) |
|---|---|
| 3个月内价格变化: | -63.34% (136400) |
| 六个月内的价格变化: | -63.34% (136400) |
| 每年价格变化: | +1 392.54% (3350) |
| 3年内价格变化: | +3 999 900% (1.25) |
| 5年内价格变化: | +171 132.88% (29.2) |
| 年初以来价格变化: | -63.45% (136800) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Boxer Capital, LLC | 4207086 | 14.3 |
| Samsara BioCapital, LLC | 700421 | 2.38 |
| Acadian Asset Management. LLC | 384995 | 1.31 |
| Hennion & Walsh Asset Management, Inc. | 69264 | 0.18 |
| Tower Research Capital LLC (TRC) | 43752 | 0.15 |
| SIMPLEX TRADING, LLC | 2000 | 0.01 |
| BESSEMER GROUP, INCORPORATED | 230 | 0 |
| Newbridge Financial Services Group, Inc. | 47 | 0 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Kevin C. Tang | Chairman & CEO | 1 | 1967 (58 年) |
| Mr. Michael S. Hearne | CFO & Principal Accounting Officer | 251.23k | 1963 (62 年) |
| Mr. Ryan Cole | Senior Vice President of Operations | N/A | |
| Dr. Steven S. Pfeiffer Ph.D. | Senior Vice President of Technical Operations | N/A | 1976 (49 年) |
| Mr. Thomas Wei | Chief Scientific Officer | N/A | 1976 (49 年) |
地址: United States, New York. NY, 3 East 28th Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.odonate.com
网站: https://www.odonate.com
